Admedus has announced the complete transfer of its sterilisation method as part of its Adapt tissue treatment process to 4C Medical. As per the Admedus supply agreement with 4C Medical, 4C Medical will pay an additional $US1 Million ($US 0.44M previously received) to use the technology to sterilise the Adapt tissue incorporated in its transcatheter [...]
Maurizio Taramasso Maurizio Taramasso (Department of Cardiac Surgery, University Hospital of Zurich, University of Zurich, Zurich, Switzerland) and colleagues write in EuroIntervention that transcatheter mitral valve repair and transcatheter mitral valve replacement (TMVR) “will most likely be complementary rather than competitive” therapies, adding that a “repair-first” (followed by TMVR if needed) “seems [...]
InnovHeart—a developer of novel transcatheter mitral valve replacement (TMVR) systems—has appointed medical device entrepreneur J Brent Ratz as non-executive independent member of its Board of Directors. A press release reports that Ratz has more than 19 years of experience in the medical device industry. He is currently co-founder and managing director of inQB8 Medical [...]
A press release reports that LivaNova is to discontinue its Caisson transcatheter mitral valve replacement programme and will undertake a restructuring of its heart valve business to improve profitability and ensure business continuity. It adds that LivaNova’s heart valve business line represented nearly $130 million in revenue for full-year 2018 and has experienced a [...]